Literature DB >> 24853318

Capsule endoscopic findings correlate with fecal calprotectin and C-reactive protein in patients with suspected small-bowel Crohn's disease.

Charlotte M Höög1, Lars-Åke Bark, Olle Broström, Urban Sjöqvist.   

Abstract

OBJECTIVE: Capsule endoscopy (CE) is a sensitive method for detecting inflammatory lesions in the small bowel. Such lesions may be due to Crohn's disease but also to other causes and a histological diagnosis may be difficult to achieve in the small bowel. The aim of the study was to find a possible correlation between capsule endoscopic findings, biochemical parameters, and symptoms in patients with suspected or known small-bowel Crohn´s disease.
MATERIALS AND METHODS: Thirty patients with inflammatory lesions in the small bowel diagnosed by CE were included. CE findings of inflammation were graded using the Lewis score. C-reactive protein (CRP) and fecal calprotectin were used as biochemical parameters. Symptoms were graded using the Harvey-Bradshaw index. The patients were followed up after 9 months with a second CE, CRP, fecal calprotectin, and Harvey-Bradshaw index.
RESULTS: There was a significant persistent correlation between endoscopic inflammation and fecal calprotectin (p = 0.003 at inclusion and p < 0.001 at follow-up). CRP was correlated to endoscopic inflammation at inclusion (p = 0.006), but not at follow-up. Symptoms were not correlated with endoscopic inflammation.
CONCLUSION: Inflammatory lesions in the small bowel diagnosed by CE in patients with suspected Crohn´s disease are correlated to fecal calprotectin and CRP, but not to symptoms.

Entities:  

Keywords:  Crohn´s disease; Lewis score; capsule endoscopy; fecal calprotectin

Mesh:

Substances:

Year:  2014        PMID: 24853318     DOI: 10.3109/00365521.2014.920915

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Usefulness of the capsule endoscopy Crohn's disease activity index in assessing the necessity of early additional treatment in patients with Crohn's disease in clinical remission.

Authors:  Takahiro Miyazu; Natsuki Ishida; Ryosuke Takano; Satoshi Tamura; Mihoko Yamade; Yasushi Hamaya; Shinya Tani; Moriya Iwaizumi; Satoshi Osawa; Takahisa Furuta; Ken Sugimoto
Journal:  Medicine (Baltimore)       Date:  2021-07-23       Impact factor: 1.817

2.  Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease.

Authors:  Birgit Adam; Michael Koldehoff; Markus Ditschkowski; Tanja Gromke; Michal Hlinka; Rudolf Trenschel; Lambros Kordeals; Nina K Steckel; Dietrich W Beelen; Tobias Liebregts
Journal:  Dig Dis Sci       Date:  2016-03-19       Impact factor: 3.199

3.  Association Between Fecal Calprotectin Levels and Small-bowel Inflammation Score in Capsule Endoscopy: A Multicenter Retrospective Study.

Authors:  Anastasios Koulaouzidis; Taina Sipponen; Artur Nemeth; Richard Makins; Uri Kopylov; Moshe Nadler; Andry Giannakou; Diana E Yung; Gabriele Wurm Johansson; Leonidas Bartzis; Henrik Thorlacius; Ernest G Seidman; Rami Eliakim; John N Plevris; Ervin Toth
Journal:  Dig Dis Sci       Date:  2016-03-23       Impact factor: 3.199

4.  Dissecting Lewis score under the light of fecal calprotectin; an analysis of correlation of score components with calprotectin levels in capsule endoscopy.

Authors:  Anastasios Koulaouzidis; Artur Nemeth; Gabriele Wurm Johansson; Ervin Toth
Journal:  Ann Gastroenterol       Date:  2015 Apr-Jun

5.  Faecal biomarkers for screening small bowel inflammation in patients with Crohn's disease: a prospective study.

Authors:  Takahiro Shimoyama; Takayuki Yamamoto; Satoru Umegae; Koichi Matsumoto
Journal:  Therap Adv Gastroenterol       Date:  2017-07-04       Impact factor: 4.409

6.  Capsule endoscopy findings for the diagnosis of Crohn's disease: a nationwide case-control study.

Authors:  Motohiro Esaki; Takayuki Matsumoto; Naoki Ohmiya; Ema Washio; Toshifumi Morishita; Kei Sakamoto; Hiroo Abe; Shojiro Yamamoto; Tetsu Kinjo; Kazutomo Togashi; Kenji Watanabe; Fumihito Hirai; Masanao Nakamura; Sadaharu Nouda; Shinya Ashizuka; Teppei Omori; Shuji Kochi; Shunichi Yanai; Yuta Fuyuno; Atsushi Hirano; Junji Umeno; Takanari Kitazono; Fukunori Kinjo; Mamoru Watanabe; Toshiyuki Matsui; Yasuo Suzuki
Journal:  J Gastroenterol       Date:  2018-09-15       Impact factor: 7.527

7.  Influence of proton pump inhibitor therapy on intestinal inflammation assessed by fecal calprotectin in pediatric patients.

Authors:  Su Yeong Kim; Na Mi Lee; Sin Weon Yun; Soo Ahn Chae; In Seok Lim; Eung Sang Choi; Dae Yong Yi
Journal:  Korean J Pediatr       Date:  2019-07-03

8.  Association between body mass index and fecal calprotectin levels in children and adolescents with irritable bowel syndrome.

Authors:  Jun Hwan Kim; Dae Yong Yi; Yoo Min Lee; You Jin Choi; Ju Young Kim; Yong Hee Hong; Ji Young Park; Su Yeong Kim; Na Mi Lee; Sin Weon Yun; Soo Ahn Chae; In Seok Lim; Eung Sang Choi; In Sook Jeong
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

9.  Fecal Calprotectin for predicting Relapse and Activity in Patients with Crohn's Disease: A Meta-analysis.

Authors:  Ying Zhuge; Qiu-Ping Huang; Qing Li; Jun-Shan Wang
Journal:  Euroasian J Hepatogastroenterol       Date:  2016-12-01

10.  Fecal calprotectin as a marker of gastrointestinal involvement in pediatric Henoch-Schönlein purpura patients: a retrospective analysis.

Authors:  Eun Young Paek; Dae Yong Yi; Ben Kang; Byung-Ho Choe
Journal:  BMC Pediatr       Date:  2020-08-08       Impact factor: 2.125

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.